Correction to: Genome evolution of SARS-CoV-2 and its virological characteristics

So Nakagawa^{1

2

3}, Takayuki Miyazawa^{4

5}

Affiliations

¹ Molecular Life Science, School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan. so@tokai.ac.jp.
² Institute of Medical Sciences, Tokai University, Kanagawa, Japan. so@tokai.ac.jp.
³ Micro/Nano Technology Center, Tokai University, Hiratsuka, Japan. so@tokai.ac.jp.
⁴ Laboratory of Virus-Host Coevolution, Institute for Frontier Life and Medical Sciences, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan. takavet@infront.kyoto-u.ac.jp.
⁵ Resilience Research Unit, Kyoto University, Kyoto, Japan. takavet@infront.kyoto-u.ac.jp.

Published Erratum

So Nakagawa et al. Inflamm Regen. 2020.

. 2020 Dec 21;40(1):41.

doi: 10.1186/s41232-020-00151-6.

So Nakagawa^{1

2

3}, Takayuki Miyazawa^{4

5}

¹ Molecular Life Science, School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan. so@tokai.ac.jp.
² Institute of Medical Sciences, Tokai University, Kanagawa, Japan. so@tokai.ac.jp.
³ Micro/Nano Technology Center, Tokai University, Hiratsuka, Japan. so@tokai.ac.jp.
⁴ Laboratory of Virus-Host Coevolution, Institute for Frontier Life and Medical Sciences, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan. takavet@infront.kyoto-u.ac.jp.
⁵ Resilience Research Unit, Kyoto University, Kyoto, Japan. takavet@infront.kyoto-u.ac.jp.

No abstract available

Figures

Genome evolution of SARS-CoV-2 and its virological characteristics.
Nakagawa S, Miyazawa T. Nakagawa S, et al. Inflamm Regen. 2020 Aug 10;40:17. doi: 10.1186/s41232-020-00126-7. eCollection 2020. Inflamm Regen. 2020. PMID: 32834891 Free PMC article. Review.

1. Nakagawa S, Miyazawa T. Genome evolution of SARS-CoV-2 and its virological characteristics. Inflamm Regener. 2020;40:17. doi: 10.1186/s41232-020-00126-7. - DOI - PMC - PubMed